https://scholars.lib.ntu.edu.tw/handle/123456789/538845
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | YAO-CHANG CHEN | en_US |
dc.contributor.author | Lin K.H. | en_US |
dc.contributor.author | Huang W.S. | en_US |
dc.contributor.author | JIH-LUH TANG | en_US |
dc.date.accessioned | 2021-01-06T03:59:07Z | - |
dc.date.available | 2021-01-06T03:59:07Z | - |
dc.date.issued | 1994 | - |
dc.identifier.issn | 0268-3369 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028304423&partnerID=40&md5=52378802d9a957428f606f810bfc31ad | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/538845 | - |
dc.description.abstract | In Taiwan, a country with 21 million people, 388 bone marrow transplants (BMTs), 308 allografts and 80 autografts, were performed in 5 BMT centers from November 1983 to October 1993. The commonest indications were leukemia, aplastic anemia, lymphoma and thalassemia. Campaigns promoting an unrelated marrow donor registry were started in August 1993 and recruited approximately 26 000 volunteers. A peripheral stem cell program is just beginning. The overall results of BMT in Taiwan are comparable to other countries. The complications of BMT are similar to Western series, except that acute GVHD was rarer in one large series; this observation needs further study. A particular indication for allogeneic BMT in Taiwan is thalassemia, accounting for 10% of all patients. Disease-free survival after BMT for thalassemia is 44%; graft rejection is the major cause of treatment failure. Another important issue is the role of hepatitis B virus (HBV) in BMT, since the prevalence of HBV infection in Taiwan is very high (>90%). Abnormal liver function is currently the most common complication and might be related to HBV. Among nearly 100 allogeneic BMTs with HBV carriers as either donor or recipient, 2 patients (approximately 2%) died of HBV-related hepatic failure. Whether the HBV status of the donor and recipient is an important prognostic factor remains to be defined. | en_US |
dc.relation.ispartof | Bone Marrow Transplantation | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | allogenic bone marrow transplantation; aplastic anemia; autologous bone marrow transplantation; bone marrow transplantation; conference paper; donor; graft rejection; graft versus host reaction; hepatitis b virus; human; human cell; leukemia; liver disease; liver failure; lymphoma; major clinical study; priority journal; stem cell; survival rate; taiwan; thalassemia; volunteer; Anemia, Aplastic; Blood Transfusion, Autologous; Bone Marrow Transplantation; Graft vs Host Disease; Hepatitis B; Human; Incidence; Leukemia; Lymphoma; Registries; Support, Non-U.S. Gov't; Taiwan; Transplantation, Homologous | - |
dc.title | Bone marrow transplantation in Taiwan: An overview | en_US |
dc.type | conference paper | en_US |
dc.identifier.pmid | 7920298 | - |
dc.identifier.scopus | 2-s2.0-0028304423 | - |
dc.relation.pages | 705-708 | en_US |
dc.relation.journalvolume | 13 | en_US |
dc.relation.journalissue | 6 | en_US |
item.openairecristype | http://purl.org/coar/resource_type/c_5794 | - |
item.openairetype | conference paper | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
crisitem.author.dept | Laboratory Medicine | - |
crisitem.author.dept | Laboratory Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0003-4021-3281 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。